Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM) -- Ignore unavailable to you. Want to Upgrade?

To: Ian@SI who wrote (2681)	8/9/2006 10:34:06 PM
From: John Metcalf	Read Replies (2) \| Respond to of 3044

Maybe Peter and I over-emphasized comments earlier today about lack of animal data, which would be routinely acquired in pre-clinical studies. The initiation of an FDA-approved Phase I trial indicates that pre-clinical studies have been done and have met FDA standards for an Investigational New Drug Application. IND status generally connotes that there have been animal studies, where appropriate. As TGN showed tragically this Winter, that's not a guarantee that a drug can be safely tested in humans. But it is permission to try it.